The global lung disease therapeutics industry growth is poised for exceptional growth, projected to soar to a market value of US$ 83,398.60 million in 2023 and forecasted to surge to an impressive US$ 152,369.26 million by 2033. This substantial growth is attributed to a robust compound annual growth rate (CAGR) of 6.2% anticipated over the …